BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

208 related articles for article (PubMed ID: 22361951)

  • 1. Immunohistochemical detection of uPA, tPA, and PAI-1 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
    Nosaka M; Ishida Y; Kuninaka Y; Kimura A; Kondo T
    Int J Legal Med; 2012 May; 126(3):421-5. PubMed ID: 22361951
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of urokinase plasminogen activator and plasmin activator inhibitor-1 on vein wall remodeling in experimental deep vein thrombosis.
    Baldwin JF; Sood V; Elfline MA; Luke CE; Dewyer NA; Diaz JA; Myers DD; Wakefield T; Henke PK
    J Vasc Surg; 2012 Oct; 56(4):1089-97. PubMed ID: 22796119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Urokinase plasminogen activator independent early experimental thrombus resolution: MMP2 as an alternative mechanism.
    Sood V; Luke CE; Deatrick KB; Baldwin J; Miller EM; Elfline M; Upchurch GR; Wakefield TW; Henke PK
    Thromb Haemost; 2010 Dec; 104(6):1174-83. PubMed ID: 20886179
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of the plasminogen system in basal adhesion formation and carbon dioxide pneumoperitoneum-enhanced adhesion formation after laparoscopic surgery in transgenic mice.
    Molinas CR; Elkelani O; Campo R; Luttun A; Carmeliet P; Koninckx PR
    Fertil Steril; 2003 Jul; 80(1):184-92. PubMed ID: 12849822
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biological mechanisms underlying the clinical effects of RU 486: modulation of cultured endometrial stromal cell plasminogen activator and plasminogen activator inhibitor expression.
    Lockwood CJ; Krikun G; Papp C; Aigner S; Schatz F
    J Clin Endocrinol Metab; 1995 Apr; 80(4):1100-5. PubMed ID: 7714076
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epithelial tissue-type plasminogen activator expression, unlike that of urokinase, its receptor, and plasminogen activator inhibitor-1, is increased in chronic venous ulcers.
    Weckroth M; Vaheri A; Virolainen S; Saarialho-Kere U; Jahkola T; Sirén V
    Br J Dermatol; 2004 Dec; 151(6):1189-96. PubMed ID: 15606514
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure of thrombus to resolve in urokinase-type plasminogen activator gene-knockout mice: rescue by normal bone marrow-derived cells.
    Singh I; Burnand KG; Collins M; Luttun A; Collen D; Boelhouwer B; Smith A
    Circulation; 2003 Feb; 107(6):869-75. PubMed ID: 12591758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vein wall remodeling after deep vein thrombosis involves matrix metalloproteinases and late fibrosis in a mouse model.
    Deatrick KB; Eliason JL; Lynch EM; Moore AJ; Dewyer NA; Varma MR; Pearce CG; Upchurch GR; Wakefield TW; Henke PK
    J Vasc Surg; 2005 Jul; 42(1):140-8. PubMed ID: 16012463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced venous thrombus resolution in plasminogen activator inhibitor type-2 deficient mice.
    Siefert SA; Chabasse C; Mukhopadhyay S; Hoofnagle MH; Strickland DK; Sarkar R; Antalis TM
    J Thromb Haemost; 2014 Oct; 12(10):1706-16. PubMed ID: 25041188
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte urokinase-type plasminogen activator up-regulation reduces thrombus size in a model of venous thrombosis.
    Humphries J; Gossage JA; Modarai B; Burnand KG; Sisson TH; Murdoch C; Smith A
    J Vasc Surg; 2009 Nov; 50(5):1127-34. PubMed ID: 19703758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ELISA for complexes of urokinase-type and tissue-type plasminogen activators with their type-1 inhibitor (uPA-PAI-1 and tPA-PAI-1).
    Grebenschikov N; Sweep F; Geurts A; Andreasen P; De Witte H; Schousboe S; Heuvel J; Benraad T
    Int J Cancer; 1999 May; 81(4):598-606. PubMed ID: 10225451
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Plasminogen Activation System in Rectal Adenocarcinoma.
    Razik E; Kobierzycki C; Grzegrzolka J; Podhorska-Okolow M; Drag-Zalesinska M; Zabel M; Dziegiel P
    Anticancer Res; 2015 Nov; 35(11):6009-15. PubMed ID: 26504024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clinical value of components of the plasminogen activation system in ovarian cyst fluid.
    Boss EA; Massuger LF; Thomas CM; Geurts-Moespot A; van Schaik JH; Boonstra H; Sweep CG
    Anticancer Res; 2002; 22(1A):275-82. PubMed ID: 12017303
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The imbalance of plasminogen activators and inhibitor in preeclampsia.
    Gao M; Nakabayashi M; Sakura M; Takeda Y
    J Obstet Gynaecol Res; 1996 Feb; 22(1):9-16. PubMed ID: 8624901
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Measurement of plasminogen activator system components in plasma and tumor tissue extracts obtained from patients with breast cancer: an EORTC Receptor and Biomarker Group collaboration.
    Grebenchtchikov N; Maguire TM; Riisbro R; Geurts-Moespot A; O'Donovan N; Schmitt M; McGreal G; McDermott E; O'Higgins N; Brünner N; Sweep CG; Duffy MJ
    Oncol Rep; 2005 Jul; 14(1):235-9. PubMed ID: 15944795
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of the plasminogen activator system in the human vascular wall.
    Salame MY; Samani NJ; Masood I; deBono DP
    Atherosclerosis; 2000 Sep; 152(1):19-28. PubMed ID: 10996335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired fibrinolytic system in ApoE gene-deleted mice with hyperlipidemia augments deep vein thrombosis.
    Diaz JA; Ballard-Lipka NE; Farris DM; Hawley AE; Wrobleski SK; Myers DD; Henke PK; Lawrence DA; Wakefield TW
    J Vasc Surg; 2012 Mar; 55(3):815-22. PubMed ID: 22119245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Immunohistochemical detection of MMP-2 and MMP-9 in a stasis-induced deep vein thrombosis model and its application to thrombus age estimation.
    Nosaka M; Ishida Y; Kimura A; Kondo T
    Int J Legal Med; 2010 Sep; 124(5):439-44. PubMed ID: 20623133
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adenoviral urokinase-type plasminogen activator (uPA) gene transfer enhances venous thrombus resolution.
    Gossage JA; Humphries J; Modarai B; Burnand KG; Smith A
    J Vasc Surg; 2006 Nov; 44(5):1085-90. PubMed ID: 17098546
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Urokinase plasminogen activator, uPa receptor, and its inhibitor in vernal keratoconjunctivitis.
    Leonardi A; Brun P; Sartori MT; Cortivo R; Dedominicis C; Saggiorato G; Abatangelo G; Secchi AG
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1364-70. PubMed ID: 15790903
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.